Prevalence of psychiatric co-morbidities in patients with early musculosceletal rheumatic diseases and non inflammatory joint diseases vs.patients without any joint disease and/or pain syndroms
- Conditions
- M13.0F43Polyarthritis, unspecifiedReaction to severe stress, and adjustment disorders
- Registration Number
- DRKS00011120
- Lead Sponsor
- Charité-Universitätsmedizin BerlinKlinik m.S. Rheumatologie und Klinische Immunologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
The patient
• has nflammatory and non-inflammatory joint symptoms and/or fulfills the ACR/EULAR criteria of an early RA of 2010 with a symptom duration of at least four weeks and a maximum of 12 months
• agrees with data collection of disease data and sample collection/sample use.
Age and gender-matched control population:
• Excluded inflammatory-systemic rheumatic disease
• has no other inflammatory systemic disease of the rheumatic diseases.
For all participants:
• Age = 18 years,
• There is a written consent to the survey of self-questionnaire questionnaire
The patient
• has a known psychiatric disorder that limits the understanding of the project plan (not consentable)
• does not agree and/or is not able to sign the declaration of consent
• is a prisoner or a person placed in an institution on the basis of an administrative or judicial order
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of psychiatric co-morbidities (by means of a psychological questionnaire package as well as a structured psychiatric interview) in early arthritis patients.
- Secondary Outcome Measures
Name Time Method Determination of cytocines, sensitivity of glococorticoid receptors at timepoint of diagnosis.